Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C
β Scribed by Masanori Ikeda; Yoshinari Kawai; Kyoko Mori; Masahiko Yano; Ken-ichi Abe; Go Nishimura; Hiromichi Dansako; Yasuo Ariumi; Takaji Wakita; Kazuhide Yamamoto; Nobuyuki Kato
- Book ID
- 111239514
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 645 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
RNA interference (RNAi) is being evaluated as an alternative therapeutic strategy for hepatitis C virus (HCV) infection. The use of viral vectors encoding short hairpin RNAs (shRNAs) has been the most common strategy employed to provide sustained expression of RNAi effectors. However, overexpression
## Abstract Hepatitis C virus (HCV) is a major causative agent of liver diseases such as chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Because the current standard therapy, interferon (IFN) or pegylatedβIFN alone or in combination with ribavirin, is ineffective on approximately h